Nplate (romiplostim) — Blue Cross Blue Shield of Texas

Initial criteria

• If pediatric, ITP duration ≥ 6 months
• Platelet count ≤ 30 x 10^9/L OR 30–50 x 10^9/L with symptomatic bleeding or risk for bleeding
• AND one of: stage 4 metastatic cancer use consistent with best practices OR inadequate response/intolerance/contraindication to corticosteroids, IVIg/anti-D, splenectomy, or rituximab